Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-16

Clinical Trial Update: TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure [Phase 3]

View source ↗

Summary

The Phase 3 TRANSFORM-HF trial comparing torsemide with furosemide for management of heart failure has completed, and the results were posted on 2025-10-16. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FUROSEMIDE (Furosemide)
  • Torsemide (torsemide)

Snippet

Sponsor: Duke University | Conditions: Heart Failure | Phase 3 | Status: COMPLETED | Results posted: 2025-10-16